We are pleased to announce our attendance to the 38th AEFI Symposium, the master event of the Spanish Association of Pharmacists of the Industry.
Asphalion takes this opportunity to celebrate the recent opening of our new office in Madrid. We would like to share with you the inauguration of our new location, which is a solid milestone in our company expansion strategy. Asphalion’s Board of Directors are glad to be present at this event to reinforce the proximity to our existing client base in Spain and to the Spanish Agency, with our new consultancy center of excellence in Madrid.
It will be a great occasion to meet Asphalion management, especially our Madrid office director Dr. André Mota. You can visit us at our stand in the exhibition hall, where we will provide a little gift to represent the new company landmark.
Furthermore, Asphalion will be at AEFI gala dinner, sponsoring the music concert during the ceremony. We will present the company growth with the new Madrid center, in line with our vision to be a global reference and driving force in the Scientific and Regulatory Affairs sector.
In this sense, our team are always up to date with the latest scientific, regulatory and pharmacovigilance topics. Therefore, our specialists will participate in the congress as speakers of engaging workshops and conferences.
Asphalion participation in AEFI program:
9 May, 13:00h
- Table 4 “Regulatory future: Advantages of electronic submission”
by Remco Munnik, Asphalion Regulatory Information Director
10 May, 13:30h
- Workshop 4 “Biosimilars vs generics”
by Lidia CÌÁnovas Méndez, Asphalion General Manager – Regulatory Affairs - Workshop 5 “New Eudravigilance: practical management of L2A”
by Sonia LÌ_pez SÌÁnchez, Asphalion Drug Safety Manager
Asphalion sponsors the music concert at AEFI Gala Dinner.
